An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

NCT05376878 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Metastatic Malignant Neoplasm in the Brain

Interventions

OTHER: Copper Cu 64-DOTA-Trastuzumab
PROCEDURE: Magnetic Resonance Imaging
DEVICE: Positron Emission Tomography
BIOLOGICAL: Trastuzumab
BIOLOGICAL: Trastuzumab Deruxtecan

Sponsor

City of Hope Medical Center

Collaborators

[object Object]